Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,109
Total Claims
$1.1M
Drug Cost
1,310
Beneficiaries
$809
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+43%
Opioid rate vs peers
49.6% vs 34.8% avg
+92%
Cost per patient vs peers
$809 vs $422 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
49.6%
Opioid Rate
9,473
Opioid Claims
$341K
Opioid Cost
13.4%
Long-Acting Rate
This provider's opioid prescribing rate of 49.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 18,253 claims · $552K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 2,602 | $99K |
| Hydrocodone/Acetaminophen | 3,613 | $99K |
| Methylnaltrexone Bromide | 42 | $98K |
| Rimegepant Sulfate | 82 | $93K |
| Buprenorphine Hcl/Naloxone Hcl | 428 | $92K |
| Erenumab-Aooe | 57 | $68K |
| Pregabalin | 1,301 | $51K |
| Oxycodone Myristate | 90 | $38K |
| Gabapentin | 1,667 | $34K |
| Buprenorphine Hcl/Naloxone Hcl | 38 | $30K |
| Galcanezumab-Gnlm | 36 | $24K |
| Oxycodone Hcl | 72 | $23K |
| Tizanidine Hcl | 1,138 | $19K |
| Lidocaine | 142 | $17K |
| Diclofenac Sodium | 583 | $17K |
Prescribing Profile
52
Unique Drugs
21.0
Anomaly Score
Patient Profile
68
Avg Age
56%
Female
2.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About